Phase 2 Readout
BIOA: Phase 2 Readout: bge-102
December 31, 2026 · bge-102. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- BioAge Labs, Inc. (BIOA)
- Drug
- bge-102
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: bge-102
- Company
- BioAge Labs, Inc. (BIOA)
- Drug
- bge-102
- Indication
- obesity and cardiovascular risk factors